caffeine - CISMeF

Preferred Label : caffeine;

MeSH definition : A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.;

MeSH synonym : 1,3,7-trimethylxanthine;

CISMeF synonym : merck dura brand of caffeine; Berlin-Chemie brand of caffeine; republic drug brand of caffeine; seid brand of caffeine; GlaxoSmithKline brand of caffeine; passauer brand of caffeine; pierre fabre brand of caffeine; thompson brand 2 of caffeine; thompson brand 1 of caffeine; Bristol-Myers squibb brand of caffeine;

DeCS synonym : Percutaf ine; Quick Pep; QuickPep;

MeSH hyponym : coffeinum N; caffedrine; no doz; coffeinum purrum; Quick-Pep; dexitac; percoffedrinol N; percutaféine; vivarin; durvitan; Quick Pep; QuickPep;

MeSH CAS label : 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-;

MeSH Related Number : 58-08-2 (Caffeine);

Registry Number MeSH : 58-08-2;

Wikipedia link : https://en.wikipedia.org/wiki/Caffeine;

Codes EINECS : 200-362-1;

Is substance : O;

medicament (CISMeF) : O;

UNII : 3G6A5W338E;

InChIKey : RYYVLZVUVIJVGH-UHFFFAOYSA-N;

Details

Origin ID

D002110;

UMLS CUI

C0006644;

ATC code(s)
- caffeine [ATC Code]
- caffeine [ATC Code]
- caffeine and sodium benzoate [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- caffeine [Substance BNPC]
Currated CISMeF NLP mapping
- Caffeine [ICD-11 Extension code]
- Caffeine [LOINC component]
- Caffeine [HPMULTI term]
- Caffeine [NCIt concept]
- Caffeine (substance) [SNOMED CT concept]
- caffeine [MedlinePlus Topic]
- caffeine, nos [SNOMED Notion]
False automatic mappings
- Methylxanthines, not elsewhere classified [ICD-10 Sub-category (who)]
Indexing information
- hydroxycut [MeSH Supplementary Concept]
MedlinePlus topic(s)
- caffeine [MedlinePlus Topic]
Pharmacological action(s)
- central nervous system stimulants [MeSH Descriptor]
- neurotransmitter agents [MeSH Descriptor]
- phosphodiesterase inhibitors [MeSH Descriptor]
- purinergic P1 receptor antagonists [MeSH Descriptor]
Record concept(s)
- Quick-Pep [MeSH concept]
- caffedrine [MeSH concept]
- caffeine [MeSH concept]
- coffeinum N [MeSH concept]
- coffeinum purrum [MeSH concept]
- dexitac [MeSH concept]
- durvitan [MeSH concept]
- no doz [MeSH concept]
- percoffedrinol N [MeSH concept]
- percutaféine [MeSH concept]
- vivarin [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1,3,7,9-tetramethylxanthine-8-ylidene)silver acetate [MeSH Supplementary Concept]
- 1,3,7-trimethyldihydrouric acid [MeSH Supplementary Concept]
- 1,3-dimethyl-7-(5-ethylcarboxypentyl)xanthine [MeSH Supplementary Concept]
- 1,3-dimethyl-7-(7-hydroxyoctyl)xanthine [MeSH Supplementary Concept]
- 1-methylcaffeine [MeSH Supplementary Concept]
- 2-methylcaffeine [MeSH Supplementary Concept]
- 3-methyl-7-(7-oxooctyl)-1-propargylxanthine [MeSH Supplementary Concept]
- 6-thiocaffeine [MeSH Supplementary Concept]
- 8-(3,4,5-trimethoxystyryl)caffeine [MeSH Supplementary Concept]
- 8-(3-chlorostyryl)caffeine [MeSH Supplementary Concept]
- 8-chlorocaffeine [MeSH Supplementary Concept]
- 8-cyclohexylcaffeine [MeSH Supplementary Concept]
- 8-ethoxycaffeine [MeSH Supplementary Concept]
- 8-methoxycaffeine [MeSH Supplementary Concept]
- 8-nitrocaffeine [MeSH Supplementary Concept]
- K1 protocol [MeSH Supplementary Concept]
- KF 21213 [MeSH Supplementary Concept]
- L 5409709 [MeSH Supplementary Concept]
- LM11A-24 [MeSH Supplementary Concept]
- Migraine-Kranit [MeSH Supplementary Concept]
- N.O.-Xplode [MeSH Supplementary Concept]
- Octadon-N [MeSH Supplementary Concept]
- Vasobral [MeSH Supplementary Concept]
- acetaminophen, aspirin, caffeine drug combination [MeSH Supplementary Concept]
- acetaminophen, butalbital, caffeine drug combination [MeSH Supplementary Concept]
- acetaminophen, caffeine, carisoprodol, diclofenac drug combination [MeSH Supplementary Concept]
- acetaminophen, caffeine, guaifenesin drug combination [MeSH Supplementary Concept]
- aspirin, butalbital and caffeine drug combination [MeSH Supplementary Concept]
- aspirin, caffeine, codeine drug combination [MeSH Supplementary Concept]
- aspirin, caffeine, phenacetin drug combination [MeSH Supplementary Concept]
- aspirin, caffeine, salicylamide drug combination [MeSH Supplementary Concept]
- aspirin-oxycodone hydrochloride-oxycodone terephthalate combination [MeSH Supplementary Concept]
- bucetin, caffeine, dibenzoylthiamine, ethenzamide drug combination [MeSH Supplementary Concept]
- cafaminol [MeSH Supplementary Concept]
- caffeidine [MeSH Supplementary Concept]
- caffeidine acid [MeSH Supplementary Concept]
- caffeine citrate [MeSH Supplementary Concept]
- caffeine, camylofin, ergotamine, mecloxamine, propyphenazone drug combination [MeSH Supplementary Concept]
- caffeine, chlorcyclizine, codeine, ergotamine drug combination [MeSH Supplementary Concept]
- caffeine, chlorpheniramine, dihydrocodeine, methylephedrine drug combination [MeSH Supplementary Concept]
- caffeine, codeine, acetaminophen, propyphenazone drug combination [MeSH Supplementary Concept]
- caffeine, ephedrine drug combination [MeSH Supplementary Concept]
- caffeine, ergotamine drug combination [MeSH Supplementary Concept]
- caffeine, sodium benzoate drug combination [MeSH Supplementary Concept]
- caffeinol [MeSH Supplementary Concept]
- cellucare [MeSH Supplementary Concept]
- cofplaton [MeSH Supplementary Concept]
- cofpropamine [MeSH Supplementary Concept]
- dermolipid aqua [MeSH Supplementary Concept]
- dinitrosocaffeidine [MeSH Supplementary Concept]
- dixaphen [MeSH Supplementary Concept]
- fenalgin [MeSH Supplementary Concept]
- fencamine [MeSH Supplementary Concept]
- guarana powder [MeSH Supplementary Concept]
- impletol [MeSH Supplementary Concept]
- impletol depot bayer [MeSH Supplementary Concept]
- indoprocaf [MeSH Supplementary Concept]
- keganmin [MeSH Supplementary Concept]
- kinuya-chinnetsu [MeSH Supplementary Concept]
- lipokinetix [MeSH Supplementary Concept]
- midol [MeSH Supplementary Concept]
- migril [MeSH Supplementary Concept]
- mononitrosocaffeidine [MeSH Supplementary Concept]
- norgesic forte [MeSH Supplementary Concept]
- optalidon [MeSH Supplementary Concept]
- pasuma (tablet) [MeSH Supplementary Concept]
- pircophen [MeSH Supplementary Concept]
- proksifein [MeSH Supplementary Concept]
- propain [MeSH Supplementary Concept]
- saridon [MeSH Supplementary Concept]
- shin ruru A [MeSH Supplementary Concept]
- sig 8304 [MeSH Supplementary Concept]
- silentan [MeSH Supplementary Concept]
- solpadeine [MeSH Supplementary Concept]
- synalgos [MeSH Supplementary Concept]
- syndol [MeSH Supplementary Concept]
- tert-butyloxycarbonyl-mononitrosamidocaffeidine [MeSH Supplementary Concept]
- valcophen [MeSH Supplementary Concept]
- valetol [MeSH Supplementary Concept]
- xanthobine [MeSH Supplementary Concept]
See also
- coffee [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Caffeine [NCIt concept]
- Caffeine [LOINC component]
- Caffeine (substance) [SNOMED CT concept]
- Product containing caffeine (medicinal product) [SNOMED CT concept]
- caffeine [ATC Code]
- caffeine [MedlinePlus Topic]
- caffeine [ATC Code]
- caffeine, nos [SNOMED Notion]
Validated automatic mappings to BTNT
- caffeine [ATC Code]
Validated automatic mappings to NTBT
- Caffeine measurement (procedure) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients